Skip to main content

CORRECTION article

Front. Immunol., 27 June 2024
Sec. Vaccines and Molecular Therapeutics

Corrigendum: 1270 nm near-infrared light as a novel vaccine adjuvant acts on mitochondrial photoreception in intradermal vaccines

Yohei MakiYohei Maki1Toshihiro KushibikiToshihiro Kushibiki2Tomoya SanoTomoya Sano1Takunori OgawaTakunori Ogawa1Eri KomaiEri Komai1Shusaku TakahashiShusaku Takahashi1Etsuko KitagamiEtsuko Kitagami1Yusuke SerizawaYusuke Serizawa1Ryosuke NagaokaRyosuke Nagaoka1Shinya Yokomizo,Shinya Yokomizo1,3Takeshi OnoTakeshi Ono4Miya IshiharaMiya Ishihara2Yasushi MiyahiraYasushi Miyahira4Satoshi KashiwagiSatoshi Kashiwagi3Akihiko KawanaAkihiko Kawana1Yoshifumi Kimizuka*Yoshifumi Kimizuka1*
  • 1Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan
  • 2Department of Medical Engineering, National Defense Medical College, Tokorozawa, Japan
  • 3Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, United States
  • 4Department of Global Infectious Diseases and Tropical Medicine, National Defense Medical College, Tokorozawa, Japan

A corrigendum on
1270 nm near-infrared light as a novel vaccine adjuvant acts on mitochondrial photoreception in intradermal vaccines

by Maki Y, Kushibiki T, Sano T, Ogawa T, Komai E, Takahashi S, Kitagami E, Serizawa Y, Nagaoka R, Yokomizo S, Ono T, Ishihara M, Miyahira Y, Kashiwagi S, Kawana A and Kimizuka Y (2022). Front. Immunol. 13:1028733. doi: 10.3389/fimmu.2022.1028733

Error in Figure/Table

In the published article, there was an error in Figure 7 as published. “Day 28” was labeled in Figures 7A–D instead of “Day 21”, which is inconsistent with the main text and legend. The corrected Figure 7 and its caption appear below.

Figure 7
www.frontiersin.org

Figure 7 Effect of the near-infrared (NIR) laser adjuvant on anti-influenza immune responses. Serum anti-influenza specific (A) IgG, (B) IgG1, (C) IgG2c, (D) IgG2c/IgG1 ratio at day 21, and (E) IgG, (F) IgG1, (G) IgG2c, (H) IgG2c/IgG1 ratio at day 56. (A–H) n = 14, 14, 18, 16, 14, and 14 for no vaccine (saline), vaccine ID only (ID only), 1064 nm CW laser + vaccine ID, 1270 nm CW laser + vaccine, vaccine/alum ID (Alum), and vaccine IM, respectively. Results were pooled from three independent experiments and analyzed using the Kruskal–Wallis test followed by the Dunn’s multiple comparison test. (*p<0.05, ***p<0.001, ****p<0.0001 compared with ID only) Geometric mean with 95% CI. (I) The effect of the NIR laser adjuvant on body weight of vaccinated mice following viral challenge. Body weights were monitored daily for 2 weeks. Mean body weight ± s.e.m. n = 14, 14, 18, 16, 14, and 14 for no vaccine (saline), vaccine ID only (ID only), 1064 nm CW laser + vaccine ID, 1270 nm CW laser + vaccine, vaccine/alum ID (Alum), and vaccine IM, respectively. (J) Kaplan–Meier survival plots for 2 weeks following lethal influenza challenge; Gehan–Breslow–Wilcoxon test. (I, J) Results were pooled from three independent experiments.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: adjuvant, laser, light, mitochondria, vaccine, near-infrared, ROS- reactive oxygen species, ATP- adenosine triphosphate

Citation: Maki Y, Kushibiki T, Sano T, Ogawa T, Komai E, Takahashi S, Kitagami E, Serizawa Y, Nagaoka R, Yokomizo S, Ono T, Ishihara M, Miyahira Y, Kashiwagi S, Kawana A and Kimizuka Y (2024) Corrigendum: 1270 nm near-infrared light as a novel vaccine adjuvant acts on mitochondrial photoreception in intradermal vaccines. Front. Immunol. 15:1446711. doi: 10.3389/fimmu.2024.1446711

Received: 10 June 2024; Accepted: 18 June 2024;
Published: 27 June 2024.

Edited and Reviewed by:

Gregers Jungersen, Statens Serum Institute, Denmark

Copyright © 2024 Maki, Kushibiki, Sano, Ogawa, Komai, Takahashi, Kitagami, Serizawa, Nagaoka, Yokomizo, Ono, Ishihara, Miyahira, Kashiwagi, Kawana and Kimizuka. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yoshifumi Kimizuka, ykimizuka@ndmc.ac.jp

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.